We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+29.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.47B
AUM Growth
+$451M
(+5%)
Cap. Flow
+$1.13B
Cap. Flow
% of AUM
11.96%
Top 10 Holdings %
Top 10 Hldgs %
21.59%
Holding
903
New
107
Increased
255
Reduced
393
Closed
103
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BPMC
Blueprint Medicines
BPMC
|
+$51.9M |
| 2 |
Merck
MRK
|
+$50.9M |
| 3 |
Danaher
DHR
|
+$45.3M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$37.8M |
| 5 |
JD.com
JD
|
+$37.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$103M |
| 2 |
Alibaba
BABA
|
+$98.6M |
| 3 |
Salesforce
CRM
|
+$62.5M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$59.4M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$48.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.61% |
| 2 | Technology | 20.94% |
| 3 | Consumer Discretionary | 8.9% |
| 4 | Financials | 8.59% |
| 5 | Communication Services | 7.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Royal Gold
RGLD
$16.7B
| – | – |
-1,935
| Closed | -$232K |
|
827
Raymond James Financial
RJF
$33.9B
| – | – |
-43,643
| Closed | -$2.54M |
|
828
Revvity
RVTY
$12.4B
| – | – |
-40,000
| Closed | -$3.8M |
|
829
Banco Santander
SAN
$199B
| – | – |
-682,927
| Closed | -$2.65M |
|
830
Service Corp International
SCI
$11.7B
| – | – |
-46,467
| Closed | -$2.09M |
|
831
Sea Limited
SE
$64.6B
| – | – |
-17,000
| Closed | -$668K |
|
|
SPR
832
DELISTED
Spirit AeroSystems
SPR
| – | – |
-27,128
| Closed | -$1.93M |
|
833
State Street SPDR S&P 500 ETF Trust
SPY
$784B
| – | – |
-1,065
| Closed | -$312K |
|
834
SS&C Technologies
SSNC
$18.7B
| – | – |
-52,355
| Closed | -$3.14M |
|
835
STAAR Surgical
STAA
$1.13B
| – | – |
-39,000
| Closed | -$1.34M |
|
836
Southwest Gas
SWX
$6.75B
| – | – |
-9,523
| Closed | -$707K |
|
837
Theravance Biopharma
TBPH
$875M
| – | – |
-277,700
| Closed | -$7.03M |
|
838
Travel + Leisure Co
TNL
$4.79B
| – | – |
-15,723
| Closed | -$794K |
|
839
Tapestry
TPR
$30.3B
| – | – |
-23,405
| Closed | -$617K |
|
840
Targa Resources
TRGP
$56.6B
| – | – |
-26,239
| Closed | -$1.05M |
|
841
Tyson Foods
TSN
$21.7B
| – | – |
-3,959
| Closed | -$352K |
|
842
United Airlines
UAL
$40B
| – | – |
-39,027
| Closed | -$3.36M |
|
843
Unum
UNM
$14B
| – | – |
-212,406
| Closed | -$6.05M |
|
844
VICI Properties
VICI
$30B
| – | – |
-9,873
| Closed | -$247K |
|
845
Vanda Pharmaceuticals
VNDA
$309M
| – | – |
-266,000
| Closed | -$4.27M |
|
846
Weibo
WB
$1.95B
| – | – |
-5,000
| Closed | -$227K |
|
847
Warner Bros
WBD
$64.1B
| – | – |
-41,136
| Closed | -$1.32M |
|
848
WEC Energy
WEC
$37.4B
| – | – |
-2,189
| Closed | -$197K |
|
849
WEX
WEX
$6.2B
| – | – |
-9,029
| Closed | -$1.85M |
|
850
Xerox
XRX
$357M
| – | – |
-155,531
| Closed | -$5.61M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2020 Portfolio in Review
As of Q2 2020, Candriam SCA held 903 positions worth $9.47B, up 5% from $9.02B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Candriam SCA deployed $1.13B of net new capital in Q2 2020, opening 107 new positions and adding to 255 existing holdings. Its largest new stake was JD.com: 744,410 shares worth $44.8M.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $103M trimmed.
- Candriam SCA's largest Q2 2020 buy was JD.com: 744,410 shares worth $44.8M.
- Candriam SCA added most to Blueprint Medicines in Q2 2020, an estimated $51.9M increase.
- Candriam SCA's biggest Q2 2020 reduction was Regeneron Pharmaceuticals, cutting an estimated $103M.
- Candriam SCA fully exited Salesforce in Q2 2020, selling an estimated $62.5M.
- Candriam SCA's ten largest holdings make up 22% of its $9.47B portfolio in Q2 2020.
- Candriam SCA opened 107 new positions and closed 103 in Q2 2020.
- Candriam SCA's portfolio value rose 5% quarter-over-quarter to $9.47B.
Based on Candriam SCA's 13F filing for Q2 2020, filed 23 Jul 2020.